Gangrene medical therapy: Difference between revisions

	Gangrene Microchapters
Home
Patient Information
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Gangrene from other Diseases
Epidemiology and Demographics
Risk Factors
Natural History, Complications and Prognosis
Diagnosis
History and Symptoms
Physical Examination
Laboratory Findings
X Ray
CT
MRI
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Surgery
Primary Prevention
Secondary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Gangrene medical therapy On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Gangrene medical therapy All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Gangrene medical therapy
CDC on Gangrene medical therapy
Gangrene medical therapy in the news
Blogs on Gangrene medical therapy
Directions to Hospitals Treating Gangrene
Risk calculators and risk factors for Gangrene medical therapy

Revision as of 05:42, 24 March 2022

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Edzel Lorraine Co, D.M.D., M.D.

@@ Line 5: / Line 5: @@
 ==Overview==
-As early as 1028, when antibiotics had not yet been discovered, [[fly]] [[maggot]]s were commonly used to treat chronic wounds or [[ulcer]]s to prevent or arrest necrotic spread, as some species of [[maggot]]s consume only dead flesh, leaving nearby living tissue unaffected. This practice largely died out after the introduction of [[antibiotics]] and [[enzyme]] to the range of treatments for wounds. Recently, however, [[maggot therapy]] has regained some credibility and is sometimes employed with great efficacy in cases of chronic tissue necrosis.
 ==References==